Melatonin-containing double-layered osmotic pump controlled release tablet and preparation method thereof

An osmotic pump controlled release and melatonin technology, which is applied in the directions of medical preparations containing active ingredients, medical preparations without active ingredients, and pharmaceutical formulas, can solve the problem of short biological half-life of melatonin, inability to stably release drugs, Drug release rate interference and other problems to achieve the effect of enhancing immunity, ensuring sleep time, and high utilization

Active Publication Date: 2014-12-31
CHANGZHOU ORFAMA PHARM TECH CO LTD
View PDF5 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, since the biological half-life of melatonin is very short, only about 35 minutes, to maintain a suitable duration of action, it needs to be prepared as a controlled release preparation
At present, there is no controlled-release preparation containing melatonin on the market. Chinese patent CN1195525A describes an erosion-type sustained-release preparation containing melatonin. The release data of the preparation is not given, and the sustained-release preparation usually cannot be accurately pressed. The "zero-order" drug-time curve releases drugs stably, especially for sustained-release preparations such as erosion type and matrix type. After taking them, the surface is affected by gastric juice and food wrapping, and the drug release rate will be greatly disturbed.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Melatonin-containing double-layered osmotic pump controlled release tablet and preparation method thereof
  • Melatonin-containing double-layered osmotic pump controlled release tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Such as figure 1 As shown, the osmotic pump controlled-release tablet containing melatonin described in the embodiment of the present invention is composed of an osmotic pump tablet and a moisture-proof protective film on its outer layer, wherein the osmotic pump tablet includes a double-layer tablet core and a coating half. Permeable membrane 1, the outer surface of the double-layer tablet core is wrapped with a semipermeable membrane 1 and a drug release hole 2 is added on the semipermeable membrane 1, the upper layer of the double-layer tablet core is a melatonin-containing drug layer 3, The lower layer is the push layer 4 containing osmotic pressure active substances. When the controlled-release tablet enters the gastric juice, the moisture-proof protective film on the outer layer disintegrates rapidly, and the melatonin in the protective film is completely released, providing the human body with the first burst dose. Then, The water molecules in the digestive tract...

Embodiment 2

[0036] Such as figure 1 As shown, the osmotic pump controlled-release tablet containing melatonin described in the embodiments of the present invention, the controlled-release tablet formula is as follows:

[0037] ①Based on the total dosage per 1000 tablets, the melatonin-containing drug layer 3 is composed of the following materials:

[0038] Melatonin 3g, sodium chloride 60g, mannitol 30g, lactose 30g, dextrin 10g, polyethylene oxide (molecular weight 300,000, PEO) 1.0g, polyvinylpyrrolidone (PVP K29 / 32) 6g, stearic acid Magnesium 1.4g and appropriate amount of ethanol;

[0039] ②Based on the total dosage per 1000 tablets, the push layer 4 containing osmotic pressure active substances is composed of the following materials:

[0040] Sodium chloride 40g, lactose 15g, polyethylene oxide (molecular weight 5 million, PEO) 40g, polyvinylpyrrolidone (PVP K29 / 32) 9.5g, iron oxide red 1g, magnesium stearate 1g and ethanol amount;

[0041] ③Based on the total dosage per 1000 piec...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a melatonin-containing double-layered osmotic pump controlled release tablet and a preparation method thereof. The melatonin-containing double-layered osmotic pump controlled release tablet comprises an osmotic pump basic tablet and a moistureproof protective membrane at the outer layer of the basic tablet, wherein the osmotic pump basic tablet comprises a double-layered tablet core and a coating semipermeable membrane; the semipermeable membrane layer covers the outer surface of the double-layered tablet core; the upper layer of the double-layered tablet core serves as a melatonin-containing drug layer, while the lower layer serves as a driving layer containing an osmotic pressure active substance; a drug release hole is formed in the semipermeable membrane. The melatonin-containing double-layered osmotic pump controlled release tablet and the preparation method disclosed by the invention have the benefits that the double-layered osmotic pump controlled release technology is adopted, when the controlled release tablet is taken, the tablet can absorb moisture in gastric juice, and the tablet core driving layer generates a large osmotic pressure to continuously and strongly push out the drug from the hole in the semipermeable membrane until the driving layer occupies the whole space in the semipermeable membrane, so that compared to the single-layered tablet, the controllability of the drug is better, and the availability is higher; the tablet can be clinically used for promoting sleep, regulating sleep quality, increasing immunity, resisting aging and the like.

Description

technical field [0001] The invention relates to a drug controlled-release preparation, in particular to a double-layer osmotic pump controlled-release tablet containing melatonin and a preparation method thereof. Background technique [0002] Melatonin is an indole hormone secreted by the pineal gland of humans and animals. It has a wide range of physiological activities and can control and coordinate the human immune system, nervous system, endocrine system, and reproductive system. It has anti-stress, anti-lipid Peroxidation, involved in activities such as sedative, hypnotic, analgesic and interest-free effects. At home and abroad, it has been widely used as a healthy food for anti-aging, enhancing immunity, preventing cardiovascular diseases, cancer and various senile diseases, maintaining normal sexual function, and improving sleep. [0003] With the growth of age, the melatonin secreted by the body decreases significantly, with an average decrease of 10-15% every 10 ye...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/28A61K9/24A61K31/4045A61K47/34A61K47/32A61K47/26A61P25/20A61P39/06A61P37/04
Inventor 马建国赵昱李贝贝王奕兰桑泽延
Owner CHANGZHOU ORFAMA PHARM TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products